TNFSF13B and depressive symptom measurement: The depression subgroup only had significantly increased CD30 (corrected p < 0.01) level at remission, while BAFF had the trend of elevation at remission but with no statistical significance (nominal p < 0.05, corrected p > 0.05, Supplementary Fig. 2B).